StageZero Life Sciences Ltd (SZLS) — Capital Reinvestment Ratio

Latest as of March 2015: 0.00x

StageZero Life Sciences Ltd (SZLS) has a Capital Reinvestment Ratio of 0.00x as of March 2015, meaning it reinvests 0% of its operating cash flow (CA$187.19K) in capital expenditures (CA$608.14). See SZLS net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$187.19K

CAD

Capital Expenditures

CA$608.14

CAD

Data as of

Mar 2015

Most recent filing

Annual Capital Reinvestment Ratio for StageZero Life Sciences Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for StageZero Life Sciences Ltd from None to None. For live market cap and broader valuation context, see SZLS market cap.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow